These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29988762)

  • 1. A rare complication; retained needle during intracavernosal injection for erectile dysfunction.
    Wren J; Huang IS; Gillis V; Rizo-Palomera R; Brannigan R; Bennett N
    Urol Case Rep; 2018 Sep; 20():51-53. PubMed ID: 29988762
    [No Abstract]   [Full Text] [Related]  

  • 2. Breakage of Needle during Intracavernosal Injection and Use of Portable Ultrasound Guidance for Removal.
    Hsiao W; Lian F; Goodgame B; Ritenour CW; Angell J; Master VA
    Case Rep Urol; 2013; 2013():215492. PubMed ID: 23819095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments.
    Kucuk EV; Tahra A; Bindayi A; Onol FF
    Andrology; 2016 Sep; 4(5):952-6. PubMed ID: 27368423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple retained needles: an unusual complication of intracavernous self-injection.
    Bandi G; Rajpurkar A; MacDonald MF; Dhabuwala CB
    Urology; 2005 Apr; 65(4):797. PubMed ID: 15833537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy.
    Sexton WJ; Benedict JF; Jarow JP
    J Urol; 1998 Mar; 159(3):811-5. PubMed ID: 9474156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.
    Kaplan SA; Reis RB; Kohn IJ; Shabsigh R; Te AE
    Urology; 1998 Nov; 52(5):739-43. PubMed ID: 9801091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a needle-free high-pressure injection system with needle-tipped injection of intracavernosal alprostadil for erectile dysfunction.
    Harding LM; Adeniyi A; Everson R; Barker S; Ralph DJ; Baranowski AP
    Int J Impot Res; 2002 Dec; 14(6):498-501. PubMed ID: 12494285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of retained needle in a transgender woman's phallus.
    Pan S; D'Amico MJ; Munarriz R
    Can J Urol; 2019 Aug; 26(4):9867-9870. PubMed ID: 31469645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell therapy in treatment of erectile dysfunction: autologous or allogeneic cell sources?
    Mangir N; Akbal C; Tarcan T; Simsek F; Turkeri L
    Int J Urol; 2014 Dec; 21(12):1280-5. PubMed ID: 25074479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of creating andrology units on the treatment of erectile dysfunction with intracavernosal injections].
    Ramada Benlloch FJ; Navalon Verdejo P; Claramonte Ramon FJ; Beltrán Mesenguer JF; Ramos de Campos M; Zaragozá Orts J
    Arch Esp Urol; 1999 Apr; 52(3):257-61. PubMed ID: 10371742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
    Purvis K; Egdetveit I; Christiansen E
    Int J Impot Res; 1999 Oct; 11(5):287-99. PubMed ID: 10553808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported pain with initial intracavernosal injection.
    Albaugh J; Ferrans CE
    J Sex Med; 2009 Feb; 6(2):513-9. PubMed ID: 19215617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A "Needling" Complication.
    Banerji JS; Govier FE
    Urology; 2016 Nov; 97():e5. PubMed ID: 27392650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Strategy With Oral Phosphodiesterase Type 5 Inhibition and Intracavernosal Implantation of Mesenchymal Stem Cells Is Superior to Individual Approaches in the Recovery of Erectile and Cavernosal Functions After Cavernous Nerve Injury in Rats.
    Martínez-Salamanca JI; Zurita M; Costa C; Martínez-Salamanca E; Fernández A; Castela A; Vaquero J; Carballido J; Angulo J
    J Sex Med; 2016 Jan; 13(1):1-11. PubMed ID: 26755080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intraurethral liposomal and intracavernosal prostaglandin-E1 in the management of erectile dysfunction.
    Engelhardt PF; Plas E; Hübner WA; Pflüger H
    Br J Urol; 1998 Mar; 81(3):441-4. PubMed ID: 9523667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Cyclic GMP Export by Multidrug Resistance Protein 4: A New Strategy to Treat Erectile Dysfunction?
    Boydens C; Pauwels B; Vanden Daele L; Van de Voorde J
    J Sex Med; 2017 Apr; 14(4):502-509. PubMed ID: 28258955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
    Linet OI; Ogrinc FG
    N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies for diabetic patients suffering from erectile dysfunction.
    Chen Y; Dai Y; Wang R
    Expert Opin Pharmacother; 2008 Feb; 9(2):257-66. PubMed ID: 18201148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the current role of intracavernosal injection in management of erectile dysfunction?
    El-Sakka AI
    Int J Impot Res; 2016 May; 28(3):88-95. PubMed ID: 27076113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.